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Wetting timeAbstract Even that orodispersible tablets (ODTs) have been successfully used in therapy for more
than 20 years, there is still no compendial method of their disintegration time evaluation other than
the pharmacopoeial disintegration test conducted in 800–900 mL of distilled water. Therefore,
several alternative tests more relevant to in vivo conditions were described by different researchers.
The aim of this study was to compare these methods and correlate them with in vivo results. Six
series of ODTs were prepared by direct compression. Their mechanical properties and disintegra-
tion times were measured with pharmacopoeial and alternative methods and compared with the
in vivo results. The highest correlation with oral disintegration time was found in the case of
own-construction apparatus with additional weight and the employment of the method proposed
by Narazaki et al. The correlation coefficients were 0.9994 (p< 0.001), and 0.9907 (p< 0.001)
respectively. The pharmacopoeial method correlated with the in vivo data much worse
(r = 0.8925, p< 0.05). These results have shown that development of novel biorelevant methods
of ODT’s disintegration time determination is eligible and scientifically justified.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Orodispersible tablets (orally disintegrating tablets – ODT)
were developed in late 80s and introduced to the market in
early 90s. Since then, they have become well known solution
to overcome difficulties in swallowing solid oral dosage forms
commonly encountered in geriatric or pediatric populations
(Bandari et al., 2008; Bhowmik et al., 2009). They were intro-
duced to the European Pharmacopoeia for the first time in
2004, and are described as an uncoated tablets intended to
be placed in the mouth where they disperse rapidly before
438 W. Brniak et al.being swallowed (The European Pharmacopoeia 7th Edition,
2010). The usually applied methods of quality assessment of
ODTs include evaluation of their mechanical properties, disin-
tegration time measurement, dissolution studies, taste masking
efficiency and stability tests. According to the Eur. Pharm. 7.0
orodispersible tablets should disintegrate in less than 3 min.
Food and Drug Administration in Guidance for Industry rec-
ommends that this time should not exceeded 30 s (US
Department of Health and Human Services, 2008). However,
up to now, the compendial method used to measure the disin-
tegration time of ODTs is the same as for uncoated tablets,
and there is no other method uniquely designed for ODT dis-
integration evaluation accepted by the official authorities. The
pharmacopoeial test is conducted in a one liter beaker with
approximately 800–900 mL of distilled water, which com-
pletely does not reflect the conditions in the human mouth,
and was previously reported by many researchers (Abdelbary
et al., 2005; Bi et al., 1996; Brniak et al., 2013; Harada et al.,
2006, 2010; Kakutani et al., 2010; Szakonyi and Zelkó,
2013). Even if it can be valuable in the quality assessment of
tablets, it is rather useless for the prediction of real in vivo dis-
integration time on the development stage. Therefore, there are
alternative methods proposed by many authors that reflect to a
greater degree the disintegration process in the human oral
cavity (Abdelbary et al., 2005; Bi et al., 1996; Brniak et al.,
2013; Harada et al., 2006, 2010; Kakutani et al., 2010;
Szakonyi and Zelkó, 2013; Morita et al., 2002; Rawas-Qalaji
et al., 2009; Narazaki et al., 2004; Sunada and Bi, 2002). The
simplest methods include disintegration of tablets placed in a
small volume of water in a test-tube or a petri dish (Rawas-
Qalaji et al., 2009). Another approach is to use a wire cloth
or a sieve (Bandari et al., 2008; Motohiro et al., 2001). The tab-
lets placed on the wire cloth are wetted by a water dropping
from a syringe or they are immersed in a disintegration med-
ium when put on the metal sieve. The more complex methods
involve using texture analyzers with many different probes that
are usually individually designed for ODTs (Abdelbary et al.,
2005; Szakonyi and Zelkó, 2013). There are also several testing
apparatus constructed to reflect the conditions of human
mouth in order to predict in vivo disintegration time (Brniak
et al., 2013; Harada et al., 2006, 2010; Kakutani et al., 2010;
Rawas-Qalaji et al., 2009; Narazaki et al., 2004). Another
analytical approach is to use high speed image registration
tools such as CCD camera to record the changes of the tablet
shape and its surface during disintegration (Morita et al.,
2002). Magnetic resonance imaging technique was also used
to analyze the disintegration behavior of wetted orodispersible
tablets (Brniak et al., 2013).
The apparatus used for disintegration time measurement
can work in static or dynamic conditions, i.e. the disintegra-
tion process can be caused only by the water capillary actionTable 1 Composition of tablets.




F-MELT type C –
Magnesium stearate 1.0
a – the low compression force, b – the medium compression force, c – thor some additional forces caused by the apparatus move-
ment such as shearing, grinding or pressure put on the tab-
let. The authors of alternative methods have demonstrated
the higher correlation of their results with in vivo disintegra-
tion time in comparison to the compendial test, which
proved the superiority of their approaches. However, all
tests were performed with different tablets and in different
laboratories, thus it can be confusing when trying to com-
pare the results.
Therefore, the aim of this study was to compare different
methods used for evaluation of orodispersible tablets on the
same series of orally disintegrating tablets and analyze their
correlation with disintegration time measured in vivo.2. Materials and methods
2.1. Materials
The ready to use co-processed excipient designed for ODT
direct compression, i.e. F-MELT type C (Fuji Chemical
Industry, Japan) was kindly provided by Harke Pharma
GmbH. Kollidon CL (BASF, Germany) was used as a super-
disintegrant, microcrystalline cellulose – Avicel PH-101 (FMC
Biopolymer) as a filler, and magnesium stearate (POCh,
Poland) as a lubricant.2.2. Preparation of tablets
Two kinds of model placebo tablets were prepared (Table 1).
The first ones contained microcrystalline cellulose (Avicel
PH-101) and 5% of superdisintegrant Kollidon CL. The sec-
ond ones were composed of co-processed excipient F-MELT
type C. Magnesium stearate in amount of 1% was used for
both formulations as a lubricant. Tablets with a diameter of
6 mm and a mass of 130 ± 10 mg were directly compressed
with a rotary tablet press (Erweka TRB10). Three different
compression forces were used for every composition in order
to differentiate the tablets’ mechanical properties.
2.3. Tablets’ mechanical properties
In order to determine the uniformity of mass, 20 undusted
tablets were individually weighted. Their average masses and
percent deviations were calculated according to the method
described in the European Pharmacopoeia 7.0.
The thickness and hardness of six tablets from every batch
was measured with a VK200 tablet tester (Vankel, USA). Their
tensile strength (MPa) was calculated from the equation:





e high compression force.
Comparison of ODT disintegration methods 439where F is the tablet hardness (N), D its diameter (m) and h its
thickness (m).
The friability of all prepared formulations was measured
according to the Eur. Pharm 7.0 (3). Twenty undusted tablets
were weighted, put into the Roche friabilator for 100 cycles,
undusted and weighted again. The percentage loss of their
initial mass was calculated.
2.4. Fineness of dispersion
The fineness of dispersion test according to the Eur. Pharm.
7.0 was performed in the following manner. Two tablets were
placed in a beaker with 100 mL of distilled water, and stirred
until completely dispersed. Dispersion was poured through a
sieve screen 0.7 mm. If all the parts passed through the sieve,
the tablets passed the test. If there were any remaining particles
they did not.
2.5. Tablets disintegration in vitro
The test described in European Pharmacopoeia 7.0 as well as
six other different methods (Table 2) were used to measure
disintegration time of prepared ODTs (Bi et al., 1996; Brniak
et al., 2013; Harada et al., 2006, 2010; Rawas-Qalaji et al.,
2009; Narazaki et al., 2004). The experiments on tablets of
all batches were performed six times with every method and
the average values of disintegration time and standard devia-
tions were calculated.
2.5.1. Pharmacopoeial method
The test was performed with disintegration tester ED-2






Pharmacopoeial – modified 900.0 3
Modified paddle apparatus 900.0 3
Test-tube method 2.0 A
Sieve method 4 mL/min A
Sieve method with shaker 3.0 3
Rotating shaft apparatus 450.0 3
Own construction apparatus 5.0 3
Wetting test 7.0 Athe European Pharmacopoeia 7.0 (Chapter 2.9.1. Disintegra-
tion of tablets and capsules). Distilled water in a volume of
approximately 900 mL was used as a disintegration medium.
Six tablets were placed into the tubes of the disintegration
apparatus and the test was started. The disintegration time
was measured semi-automatically.
A modification to the pharmacopoeial test proposed by
Watanabe et al. (1995) was also performed. Instead of one
plastic disk, every tablet was covered with five of them, and
only one tablet was tested during one trial. In opposition to
the pharmacopoeial test, after the apparatus was lowered
immersing the tablet into the medium, it was kept in a still
position without any further movement. All other conditions
remained the same. Six tablets of each formulation were tested.
2.5.2. Modified paddle apparatus
The method was proposed by Bi et al. (1996). A dissolution
paddle apparatus with a wire basket attached at one side of
beaker was used. The medium was mixed by the paddle at
50 rpm.
2.5.3. Test-tube method
According to the method described by Rawas-Qalaji et al.
(2009), the tablet was placed into the test-tube with 2 mL of
distilled water, and its disintegration time was measured with
a stopwatch.
2.5.4. Sieve method
Two different sieve methods were used. According to
Motohiro et al. (2001) the tablet was placed on the stainless
steel sieve (2 mm aperture), and distilled water was dropped
on its upper surface with constant speed of 4 mL/min.emperature
f medium (C)
Forces acting on the tablet
7.0 –Water wicking
–Mechanical destructive force caused
by the movement of the basket
7.0 –Water wicking
–Pressure acting on the tablet by the
five plastic disks weight
7.0 –Water wicking
–Rotating paddle causes water stirring




–Water agitation caused by
reciprocating shaker
7.0 –Water wicking
–Tablet grinding between rotating
shaft and metal plate
–Pressure caused by the load of a
rotating shaft acting on the tablet
7.0 –Water wicking
–Tablet grinding between rotating
shaft and metal plate
–Pressure caused by the load of a
rotating shaft acting on the tablet
mbient –Water wicking
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In the second sieve method reported by Bhowmik et al. (2009),
a glass tube with a sieve on its bottom was used. It was
immersed in distilled water about 1 mm deep. The tablet was
dropped on the sieve, and the time measurement was started.
The tube was constantly shaken with a reciprocating bath
shaker (150 rpm).
2.5.6. Rotating shaft apparatus
An apparatus was constructed according to the proposition of
Narazaki et al. (Harada et al., 2006, 2010; Narazaki et al.,
2004). The examined tablet was placed on a wire gauze, slightly
immersed in water, and pressed by the rotary shaft toward the
gauze. Then it was grinded by the rotary motion of the shaft
until it disintegrated completely. Disintegration time was
registered automatically, when the shaft touched the wire
gauze.
2.5.7. BJKSN-13 apparatus
The own-construction apparatus, named briefly as the
‘‘BJKSN-13’’ (abbreviation of the first letters of the authors’
names and the year of the publication) was based on the idea
of Narazaki et al. (2004) and Harada et al. (2006, 2010), but
contained a lot of important modifications as previously
described in details (Brniak et al., 2013). Briefly, the volume
of medium was reduced to 5 mL, the motion of the shaft
was different, and the registration mechanism was based on
a magnetic sensor instead of an electric circuit. Real time
changes in tablet thickness during disintegration were mea-
sured and recorded by computer software. The results were
presented as disintegration profiles (tablet thickness vs. time)
and registered as graphic files. The disintegration time was cal-
culated from the profile using plot digitalizing software. Two
forms of the test were performed: the same as described in
the previous work (Brniak et al., 2013) and with additional
weight applied to the shaft imitating the pressure of the tongue
acting on the tablet (named ‘‘BJKSN-14’’).
2.6. Wetting test
The wetting test described by Bi et al. (1996) was conducted
for 6 tablets of each formulation. A tablet weighed prior to
the test was placed in a Petri dish with a red dye solution,
and the time of wetting the whole surface of the tablet was
measured. The wetted tablet was weighed and the amount of
water absorbed by the tablet was calculated. The results are
expressed as a percent (w/w) of the initial tablet weight.Table 3 Properties of prepared tablets.
Parameters Formulation name
Ka Kb
Average mass (mg) 139.9 132.3
Maximum mass deviation (%) 5.0 5.1
Tensile strength (MPa) 0.76 2.25
Thickness (mm) 4.1 3.3
Friability (%) 0.36 0.22
Fineness of dispersion Do not comply with the pharmacopo2.7. Tablets disintegration in the oral cavity
The test was performed six times with every kind of prepared
placebo tablets. Six healthy volunteers were informed about
the study protocol and signed the written informed consent.
Prior to the test, they rinsed their oral cavities with 200 mL
of water. The tablet was placed on the tongue and the time
until it disintegrated completely was measured. It was prohib-
ited to bite or chew the tablet. Only a gentle tongue movement
was allowed (Kakutani et al., 2010). Due to the safety reason,
even that tablets contained no active substance, all remaining
parts of disintegrated tablet were spit out immediately after
the test, and volunteers rinsed their mouth again with at least
200 mL of water.
2.8. In vitro/in vivo correlation of disintegration time
In vitro results measured with every method were compared to
the in vivo disintegration time. The Pearson’s correlation
coefficients were calculated with Microsoft Office 2010 Excel
analysis ToolPak. Their significance was tested with Student’s
t-test on the significance level 0.001, 0.01 and 0.05.
3. Results
3.1. Mechanical properties of tablets
The tablets’ mechanical properties are summarized in Table 3.
All prepared tablets were of excellent mechanical properties.
Friability values ranged from 0.18% to 0.36% for tablets with
Kollidon CL, and from 0.22% to 0.28% for those with
F-MELT. Also, the pharmacopoeial requirement of mass
uniformity was fulfilled by every formulation. The maximum
mass deviation was 6.2% while the value allowed by Eur.
Pharm 7.0 is 7.5%. Tensile strength ranged from 0.71 MPa
for the tablet compressed with the lowest compression force
and up to 8.25 MPa for tablets compressed with the highest
force. Tablets with F-MELT passed the fineness of dispersion
test while the ones composed of Avicel and Kollidon CL did
not, i.e. after pouring the dispersion through the test sieve
some particles still remained on the mesh.
3.2. Disintegration studies
In the presented studies, three different types of in vitro meth-
ods of tablet disintegration were used: those where the only
factor leading to the disintegration was water wicking intoKc Fa Fb Fc
138.7 126.6 132.8 135.4
6.2 3.6 2.4 2.7
8.25 0.71 2.24 3.42
2.6 3.1 2.8 2.7
0.18 0.28 0.19 0.22
eial requirement Comply with the requirement
Comparison of ODT disintegration methods 441the matrix of the tablet, the tests with water agitation or stir-
ring, and the methods where direct destructive forces were
put on the tested tablet, such as grinding or pressing with addi-
tional weight (Table 2). Therefore, disintegration tests showed
great variability in the data measured with different methods
(Table 4). The shortest registered disintegration time was
2.3 s, while the longest greatly exceeded 3 min. The values of
disintegration time measured with one method were even more
than 60 times lower than with another (e.g. results for formu-
lation Ka measured with a rotating shaft apparatus vs. the sieve
method with shaker or a modified paddle apparatus).
Moreover, the differences between in vitro and in vivo
results were also tremendous. The only similar result for all
performed tests was the elongation of disintegration time
caused by the increase in compression force during the tablet-Table 6 Correlation of in vitro results with in vivo disintegration t
Method
Own construction apparatus with additional weight (BJKSN 2014)
Rotating shaft apparatus






Sieve method with shaker
Table 4 Disintegration time of tablets (mean values and standard d
Disintegration method Disintegration tim
Formulation nam
Ka K
Tests with water wicking only
Test-tube method 11.9 ± 0.3 17
Sieve method 106.4 ± 10.8 >
Tests with water movement
Modified paddle apparatus >3 min >
Sieve method with shaker >3 min >
Tests with other forces (grinding, pressing)
Pharmacopoeial 10.1 ± 1.0 11
Pharmacopoeial – modified 9.3 ± 0.5 13
Rotating shaft apparatus 3.3 ± 0.4 5.
Own construction apparatus 10.3 ± 1.6 19
Own construction apparatus with additional weight 9.3 ± 1.3 10
Disintegration time measured in vivo
8.8 ± 3.0 11
Table 5 Wetting time and water absorption ratio of tablets.
Parameters Formulation name
Ka Kb
Wetting time (s) 4.6 ± 1.6 5.2 ± 1.9
Water absorption ratio (%) 178.3 ± 15.4 160.3 ± 17.5ing process. The same behavior was observed for the wetting
time (Table 5). On the other hand, the water absorption ratio
was inversely proportional to the compression force used dur-
ing tablet preparation. Moreover, in every case, the values of
this parameter were higher for tablets with Kollidon CL than
with F-MELT. In the case of formulations Ka–Kc, the value of
this parameter ranged from 116.6% to 178.3% while for Fa–Fc
it reached only 32.1–107.1%.
The comparison of disintegration times measured with dif-
ferent methods with in vivo results showed the best correlation
in case of own-construction apparatus with additional weight
applied to the rotating shaft (Table 6). The value of Pearson’s
correlation coefficient for this test was 0.9994 (p < 0.001).
Slightly lower values were found for the rotary shaft apparatus














b Kc Fa Fb Fc
.3 ± 1.6 101.6 ± 1.9 5.0 ± 0.6 21.4 ± 2.1 >3 min
3 min >3 min 18.2 ± 2.1 29.7 ± 6.7 >3 min
3 min >3 min 7.6 ± 2.1 19.0 ± 6.7 148.3 ± 6.6
3 min >3 min 23.1 >3 min >3 min
.8 ± 1.4 64.3 ± 7.8 7.3 ± 0.9 29.3 ± 17.7 171.6 ± 38.1
.3 ± 1.5 59.3 ± 7.6 8.3 ± 0.8 29.3 ± 10.4 160.2 ± 9.7
3 ± 1.2 67.2 ± 7.9 2.3 ± 0.4 25.7 ± 13.5 96.7 ± 15.4
.1 ± 4.9 >3 min 11.2 ± 1.9 39.5 ± 11.5 >3 min
.1 ± 1.8 97.5 ± 11.2 7.3 ± 1.2 34.4 ± 16.4 >3 min
.7 ± 6.8 89.9 ± 6.2 7.5 ± 0.9 34.4 ± 11.0 103.7 ± 16.9
Kc Fa Fb Fc
40.7 ± 8.1 4.0 ± 1.1 17.9 ± 1.7 64.5 ± 9.9
116.6 ± 24.2 107.1 ± 10.5 80.2 ± 6.2 32.1 ± 11.1
442 W. Brniak et al.p< 0.001). It is noticeable that also the simplest method with
the test-tube correlated very well with in vivo results
(r = 0.9766, p < 0.01).
The application of own-construction apparatus allowed the
registration of disintegration profiles of analyzed tablets. They
are registered with a magnetic sensor based on Hall’s effect
and show changes in the thickness of a tablet in the function
of time – as described in details in our previous work
(Brniak et al., 2013). The examples of such profiles are pre-
sented in Figs. 1 and 2. The different behavior of tablets during
the disintegration process can be observed, which is dependent
on the kind of excipients used as well as the compression force
during tableting. Disintegration profiles of tablets compressed
with lower forces (Ka and Fa) are very similar. Tablets swelled
a little and disintegrated very rapidly, i.e. in less than 10 s.
However, tablets compressed with higher forces disintegrated
in a different way. If Kollidon and MCC were present in the
matrices they swelled prior to immediate disintegration
(Fig. 1). The thickness of the tablets Kc increased by about
25% before rapid disintegration, which is visible on the plot
as a green line going up. Otherwise, tablets with F-MELT dis-
integrated gradually without any significant swelling reported
(Fig 2).Figure 1 Disintegration profiles (tablets thickness vs. time)
registered with BJKSN-14 apparatus for tablets with Kollidon.
Figure 2 Disintegration profiles (tablets thickness vs. time)
registered with BJKSN-14 apparatus for tablets with F-MELT.4. Discussion
It was previously reported in several studies that the pharma-
copoeial method used to measure disintegration time of orally
disintegrating tablets cannot be effectively used for prediction
of this parameter in vivo (Abdelbary et al., 2005; Brniak et al.,
2013). It is rather used only as a quality control parameter.
Therefore, other alternative tests reflecting more or less
in vivo conditions of ODTs disintegration in the human mouth
were proposed. In this study, we compared some of these
methods with the results achieved with our own-construction
apparatus as well as in vivo disintegration time. The applied
methods could be divided into three groups in regard to the
forces acting on the tablets during the tests.
Disintegration of tablets in the human mouth is caused by
several factors. Water from saliva causes swelling and defor-
mation of the tablet mass through the capillary action. The
pressure of the tongue causes squeezing and grinding of the
tablet between the surface of the tongue and the upper palate.
The tablet mass can also be partially or completely dissolved in
the saliva depending on the excipients and pharmaceutical sub-
stance used. It mainly occurs in the case of lyophilized formu-
lations containing water soluble drug substances, and causes
their disintegration in a matter of seconds. On the other hand,
ODTs prepared by the direct compression method usually con-
tain at least some excipients poorly soluble in water, and the
dissolution is less important in the mechanism of their
disintegration.
The results of our study showed the highest correlation of
in vitro data with disintegration time measured in vivo in the
case of methods featuring additional force applied to the tab-
lets such as grinding, shearing or pressing of the pulped wetted
tablet mass. This indicated that imitation of the tongue acting
on the tablet is important in reflecting the in vivo condition.
Therefore, tests performed without any other force acting on
the tablet other than water wicking into its matrix revealed
in most cases a longer disintegration time, and their correlation
with the in vivo results was lower. For example, the tablet dis-
integration time measured with the simple sieve method was
usually longer than the required 3 min even for formulations
disintegrating as fast as 12 s in the human mouth. The only sta-
tic method (i.e. without agitation or shearing) with good
in vivo correlation was a simple test-tube disintegration test
with Pearson’s correlation coefficient reaching a value of
0.9766 (p < 0.01).
During the studies, two different modifications of our own
novel method of disintegration time measurement were tested.
The tests were conducted in the same way as described previ-
ously (Brniak et al., 2013) as well as with additional weight
applied to the rotating shaft. The idea of this modification
came from the results of human tongue pressure measurement.
As reported in literature, the maximum isometric pressure can
vary greatly with age, and ranges from 18.5 kPa in 3 year old
children to as much as 78 kPa in adult men (Utanohara
et al., 2008; Potter and Short, 2009; Youmans et al., 2009).
It is also strongly dependent on the type of measuring equip-
ment used. The study of Utanohara et al. (2008) performed
on a group of 853 healthy subjects of both genders in the ages
20–79 reported the range of maximal tongue pressure acting on
the upper palate as 32–42 kPa. This was the value of maximal
pressure during the 7 s compression of a balloon type probe
Comparison of ODT disintegration methods 443placed in the subjects’ mouth. There is no available report in
the literature showing the pressure acting on the ODT tablet
during disintegration in human mouth. It is rather obvious,
that the value of that pressure has to be lower than the MIP.
Therefore, the value of the pressure affected by the rotating
shaft in our original study protocol (i.e. 13.5 kPa) seems to
be reasonable. However, in the present study also the experi-
ments with additional weight attached to the shaft were per-
formed. It increased pressure to as much as 42.9 kPa, which
was the similar value as MIP reported by Utanohara et al.
(2008). The modification resulted in an even higher correlation
with the in vivo results – Pearson’s correlation coefficient
increased from 0.9846 to 0.9994 with p < 0.001.
Another aspect of the presented studies was to compare the
ready to use co-processed excipient F-MELT with Kollidon
CL and MCC. Tablets with superdisintegrant and filler were
harder than those with a co-processed substance, and their dis-
integration times were usually shorter. In order to compare the
mouthfeel of tablets containing those different excipients, the
fineness of dispersion test according to the European Pharma-
copoeia 7.0 was performed. This test is required for dispersible
tablets. If they do not pass the test, it indicates that the parti-
cles of the suspension created after dispersion of a tablet in
water are too big and can give a rough and sandy feel in the
mouth. If a tablet passes the test, it means that the particles
are fine enough to be palatable for the patient. All tablets with
F-MELT passed this test which suggested that their mouthfeel
could be acceptable (Table 3). On the other hand, none of the
tablets with Kollidon CL and MCC passed the test, i.e. they
are not suitable for orodispersible tablets. The wetting test
revealed greater water absorption ratio for formulations Ka–
Kc that was caused by the high water absorbing properties of
microcrystalline cellulose, which was the main component of
those tablets. It was also easily visible on the disintegration
profiles that tablets containing Kollidon CL and MCC swelled
much more than those with F-MELT (Figs. 1 and 2). The
excessive swelling can cause an unpleasant mouthfeel and is
rather not desirable in orodispersible tablets.
5. Conclusion
This research has shown that development of novel methods of
ODT’s disintegration time measurement is eligible and scientif-
ically justified. Particularly, it is important to develop methods
that better reflect conditions in the oral cavity than the phar-
macopoeial method. The volume of medium, its temperature,
and the type of forces acting on the tablet during a disintegra-
tion test are all important factors affecting the disintegration
process. In order to mimic in vivo conditions, all these aspects
should be taken into consideration during the novel methods
development process.
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